Related Experiment Video

Updated: Aug 15, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

[The mechanisms of hepatitis C virus resistance to interferon]

Dariusz Kmieciak1

  • 1Department of Biochemistry and Molecular Biology, Karol Marcinkowski University of Medical Sciences, Swiecickiego 6 St., 60-781 Poznan, Poland. dkmiec@am.poznan.pl

Postepy Biochemii
|October 8, 2005
PubMed

Insights

Hepatitis C proteins NS5A and E2 block interferon alpha's antiviral effects by inhibiting key cellular kinases. This mechanism promotes viral protein synthesis and hinders host protein production, aiding viral persistence.

Area of Science:

  • Virology
  • Molecular Biology
  • Immunology

Context:

  • Hepatitis C virus (HCV) infection poses a significant global health challenge.
  • Interferon alpha (IFN-α) is a critical antiviral therapy for HCV.
  • Understanding mechanisms of viral resistance to IFN-α is crucial for effective treatment.

Purpose:

  • To elucidate the role of HCV non-structural protein 5A (NS5A) and envelope protein E2 in mediating resistance to interferon alpha.
  • To explore the molecular interactions between viral proteins and host cell machinery involved in antiviral response.

Summary:

  • HCV NS5A and E2 proteins bind to interferon-induced protein kinase R (PKR) and eukaryotic initiation factor 2 (eIF2).
  • This binding inactivates PKR, inhibiting eIF2 and eIF4E phosphorylation, crucial steps in protein synthesis.
  • HCV hijacks this pathway to selectively inhibit host protein synthesis while promoting viral protein production, contributing to viral persistence.

Impact:

  • Identifies a key molecular mechanism by which HCV evades interferon-based therapy.
  • Explains viral persistence within infected cells despite antiviral treatment.
  • Highlights potential therapeutic targets for overcoming interferon resistance in Hepatitis C treatment.

More Related Videos

A Protocol for Analyzing Hepatitis C Virus Replication13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...